CASP8 Back

caspase 8, apoptosis-related cysteine peptidase

External References:      Wikipedia GeneCards HUGO COSMIC Google Scholar

NCBI Description of CASP8

This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes composed of a prodomain, a large protease subunit, and a small protease subunit. Activation of caspases requires proteolytic processing at conserved internal aspartic residues to generate a heterodimeric enzyme consisting of the large and small subunits. This protein is involved in the programmed cell death induced by Fas and various apoptotic stimuli. The N-terminal FADD-like death effector domain of this protein suggests that it may interact with Fas-interacting protein FADD. This protein was detected in the insoluble fraction of the affected brain region from Huntington disease patients but not in those from normal controls, which implicated the role in neurodegenerative diseases. Many alternatively spliced transcript variants encoding different isoforms have been described, although not all variants have had their full-length sequences determined.

Community Annotation of CASP8 Add / Edit CASP8: Annotations

No community annotations yet for CASP8.
Sort mutations by: Tumor type  Mutation type  Position  
Straightedge cursor Expand

Figure notes

• "Mouse over" a mutation to see details.
• Missense green saturation indicates evolutionary conservation of the mutated positions.
• Red hashes in protein strip are splice sites.
• Blue-white-red bars are log2 copy ratio distributions (–1 to +1) from Zack et al. (2013).


CASP8 is highly significantly mutated in
Head and neck
33 patients (8%)
combined cohort
85 patients (1%)
CASP8 is significantly mutated in
10 patients (4%)
10 patients (1%)
CASP8 is near significance in
18 patients (7%)

Click on a tumor type to see its full list of significant genes.

Data details

Mutation list for CASP8